Standard BioTools Q2 EPS USD -0.07
LAB•Standard BioTools reports second-quarter results
Aug. 5 (Reuters) - Standard BioTools Q2 revenue was USD 20.1 million.
- Q2 EPS: USD -0.07
- Q2 operating income: USD -25.4 million
- Q2 adjusted EBITDA: USD -2.5 million
- Q2 pretax profit: USD -21.435 million
- Q2 gross margin: 52.4%
- Q2 adjusted gross margin: 56.3%
- Q2 net income: USD -26.758 million
